company background image
1099 logo

Sinopharm Group SZSC:1099 Stock Report

Last Price

HK$21.75

Market Cap

HK$67.9b

7D

-1.6%

1Y

-17.6%

Updated

13 Jun, 2024

Data

Company Financials +

Sinopharm Group Co. Ltd.

SZSC:1099 Stock Report

Market Cap: HK$67.9b

1099 Stock Overview

Engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China.

1099 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends5/6

Sinopharm Group Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinopharm Group
Historical stock prices
Current Share PriceHK$21.75
52 Week HighHK$26.70
52 Week LowHK$17.44
Beta0.84
1 Month Change-3.55%
3 Month Change4.82%
1 Year Change-17.61%
3 Year Change-7.64%
5 Year Change-21.34%
Change since IPO-38.65%

Recent News & Updates

Recent updates

Shareholder Returns

1099HK HealthcareHK Market
7D-1.6%-2.9%-1.5%
1Y-17.6%-23.1%-2.6%

Return vs Industry: 1099 exceeded the Hong Kong Healthcare industry which returned -22% over the past year.

Return vs Market: 1099 underperformed the Hong Kong Market which returned -2% over the past year.

Price Volatility

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.5%
Healthcare Industry Average Movement5.7%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1099 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1099's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003115,959Yong Liuwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.

Sinopharm Group Co. Ltd. Fundamentals Summary

How do Sinopharm Group's earnings and revenue compare to its market cap?
1099 fundamental statistics
Market capHK$67.87b
Earnings (TTM)HK$9.57b
Revenue (TTM)HK$644.38b

7.1x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1099 income statement (TTM)
RevenueCN¥598.32b
Cost of RevenueCN¥550.17b
Gross ProfitCN¥48.15b
Other ExpensesCN¥39.26b
EarningsCN¥8.88b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.85
Gross Margin8.05%
Net Profit Margin1.48%
Debt/Equity Ratio62.9%

How did 1099 perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

31%

Payout Ratio

Does 1099 pay a reliable dividends?

See 1099 dividend history and benchmarks
When do you need to buy 1099 by to receive an upcoming dividend?
Sinopharm Group dividend dates
Ex Dividend DateJun 17 2024
Dividend Pay DateAug 13 2024
Days until Ex dividend3 days
Days until Dividend pay date60 days

Does 1099 pay a reliable dividends?

See 1099 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.